Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl-

Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- manufacturers

  • HPK1-IN-12
  • HPK1-IN-12 pictures
  • $1980.00
  • 2026-04-20
  • CAS:2734168-51-3
  • Purity:
  • Supply Ability: 10g
Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Basic information
Product Name:Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl-
Synonyms:Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl-;HPK1-IN-12
CAS:2734168-51-3
MF:C25H24FN5O2
MW:445.49
EINECS:
Product Categories:
Mol File:2734168-51-3.mol
Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Structure
Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Chemical Properties
Boiling point 642.2±55.0 °C(Predicted)
density 1.42±0.1 g/cm3(Predicted)
pka9.74±0.40(Predicted)
Safety Information
MSDS Information
Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Usage And Synthesis
UsesHPK1-IN-12 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-12 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 85) [1].
References[1] Xie, Yuli, et al. Hpk1 inhibitor and preparation method and use thereof. Patent WO2021213317A1.
Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Preparation Products And Raw materials
Tag:Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl-(2734168-51-3) Related Product Information
Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl- FMF-06-098-1 2-Pyridinamine, 5-[2-(4-piperidinyl)-5-thiazolyl]-3-(4-pyridinylmethoxy)- BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[(6-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)oxy]-